UK Code Of Conduct Quarterly Review

16 October 1994

The UK Prescription Medicine Code of Practice Authority's current Quarterly Review is dominated by cases brought against Astra by Allen & Hanburys and vice versa, and by SmithKline Beecham against Wellcome and vice versa. Here, in brief, are the rulings.

- Astra Pharmaceuticals v Allen & Hanburys: a "Dear Nurse" letter about Diskhalers sent by Allen & Hanburys was found to contain a misleading claim, breaching Clause 7.2 of the Code;

- Allen & Hanburys v Astra: a detail aid for the Turbohaler included studies which were not directly comparable and a table which did not reflect the balance of evidence, breaching Clause 7.2, and a "Dear Doctor" letter which also breached Clause 7.2, the Code Panel ruled. The latter ruling was overturned on appeal, but the Appeal Board decided that the aid's use of an edited quotation did not accurately reflect the author's meaning, breaching Clause 11.2;

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight